Penala Soumya, Kalakonda Butchibabu, Pathakota Krishnajaneya Reddy, Jayakumar Avula, Koppolu Pradeep, Lakshmi Bolla Vijaya, Pandey Ruchi, Mishra Ashank
Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India.
Department of Preventive Dental Sciences, Alfarabi Colleges, Riyadh, Saudi Arabia.
J Res Pharm Pract. 2016 Apr-Jun;5(2):86-93. doi: 10.4103/2279-042X.179568.
Periodontitis is known to have multifactorial etiology, involving interplay between environmental, host and microbial factors. The current treatment approaches are aimed at reducing the pathogenic microorganisms. Administration of beneficial bacteria (probiotics) has emerged as a promising concept in the prevention and treatment of periodontitis. Thus, the aim of the present study is to evaluate the efficacy of the local use of probiotics as an adjunct to scaling and root planing (SRP) in the treatment of patients with chronic periodontitis and halitosis.
This is a randomized, placebo-controlled, double-blinded trial involving 32 systemically healthy chronic periodontitis patients. After SRP, the subjects were randomly assigned into the test and control groups. Test group (SRP + probiotics) received subgingival delivery of probiotics and probiotic mouthwash, and control group (SRP + placebo) received subgingival delivery of placebo and placebo mouthwash for 15 days. Plaque index (PI), modified gingival index (MGI), and bleeding index (BI) were assessed at baseline, 1 and 3 months thereafter, whereas probing depth (PD) and clinical attachment level were assessed at baseline and after 3 months. Microbial assessment using N-benzoyl-DL-arginine-naphthylamide (BANA) and halitosis assessment using organoleptic scores (ORG) was done at baseline, 1 and 3 months.
All the clinical and microbiological parameters were significantly reduced in both groups at the end of the study. Inter-group comparison of PD reduction (PDR) and clinical attachment gain (CAG) revealed no statistical significance except for PDR in moderate pockets for the test group. Test group has shown statistically significant improvement in PI, MGI, and BI at 3 months compared to control group. Inter-group comparison revealed a significant reduction in BANA in test group at 1 month. ORG were significantly reduced in test group when compared to control group.
Within the limitations of the study, the present investigation showed that the adjunctive use of probiotics offers clinical benefit in terms of pocket depth reduction in moderate pockets and reduced oral malodor parameters.
已知牙周炎具有多因素病因,涉及环境、宿主和微生物因素之间的相互作用。目前的治疗方法旨在减少致病微生物。施用有益细菌(益生菌)已成为预防和治疗牙周炎的一个有前景的概念。因此,本研究的目的是评估局部使用益生菌作为龈下刮治和根面平整(SRP)辅助手段治疗慢性牙周炎和口臭患者的疗效。
这是一项随机、安慰剂对照、双盲试验,涉及32名全身健康的慢性牙周炎患者。在进行SRP后,将受试者随机分为试验组和对照组。试验组(SRP+益生菌)接受龈下递送益生菌和益生菌漱口水,对照组(SRP+安慰剂)接受龈下递送安慰剂和安慰剂漱口水,为期15天。在基线、此后1个月和3个月时评估菌斑指数(PI)、改良牙龈指数(MGI)和出血指数(BI),而在基线和3个月后评估探诊深度(PD)和临床附着水平。在基线、1个月和3个月时使用N-苯甲酰-DL-精氨酸萘胺(BANA)进行微生物评估,并使用感官评分(ORG)进行口臭评估。
在研究结束时,两组的所有临床和微生物学参数均显著降低。除试验组中度牙周袋的PD减少(PDR)外,两组间PDR和临床附着增加(CAG)的组间比较无统计学意义。与对照组相比,试验组在3个月时PI、MGI和BI有统计学显著改善。组间比较显示试验组在1个月时BANA显著降低。与对照组相比,试验组的ORG显著降低。
在本研究的局限性范围内,本调查表明,辅助使用益生菌在减少中度牙周袋深度和降低口腔异味参数方面具有临床益处。